Efficacy of early transfusion of convalescent plasma with high‐titer SARS‐CoV ‐2 neutralizing antibodies in hospitalized patients with COVID ‐19

High-titre methylene blue-treated convalescent plasma as an early treatment for outpatients with COVID-19: a randomised, placebo-controlled trial

(2022) Andrea Alemany et al.   Lancet Respiratory Medicine

Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults

(2021) Romina Libster et al.   NEW ENGLAND JOURNAL OF MEDICINE

Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

(2021) Michael J. Joyner et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Principles of Antibody Therapy for Infectious Diseases with Relevance for COVID-19

(2021) Arturo Casadevall et al.   mBio

Severe Acute Respiratory Syndrome Coronavirus 2 Convalescent Plasma Versus Standard Plasma in Coronavirus Disease 2019 Infected Hospitalized Patients in New York

(2021) Elliott Bennett-Guerrero et al.   CRITICAL CARE MEDICINE

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

(2021) Obbina Abani et al.   LANCET

Impact of pathogen reduction methods on immunological properties of the COVID‐19 convalescent plasma

(2021) Alexander I. Kostin et al.   VOX SANGUINIS

Early Convalescent Plasma for High-Risk Outpatients with Covid-19

(2021) Frederick K. Korley et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors

(2021) Katie L. Kunze et al.   Nature Communications

Treatment of COVID-19 Patients with Convalescent Plasma

(2020) Eric Salazar et al.   AMERICAN JOURNAL OF PATHOLOGY

Effectiveness of convalescent plasma therapy in severe COVID-19 patients

(2020) Kai Duan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion

(2020) Xinyi Xia et al.   BLOOD

Poor outcome and prolonged persistence of SARS‐CoV‐2 RNA in COVID‐19 patients with haematological malignancies; King's College Hospital experience

(2020) Vallari Shah et al.   BRITISH JOURNAL OF HAEMATOLOGY

Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19

(2020) Ling Li et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A perspective on potential antibody-dependent enhancement of SARS-CoV-2

(2020) Ann M. Arvin et al.   NATURE

Convalescent plasma therapy in patients with COVID-19

(2020) Fevzi Altuntas et al.   TRANSFUSION AND APHERESIS SCIENCE

Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)

(2020) Anup Agarwal et al.   BMJ-British Medical Journal

Efficacy and safety of convalescent plasma therapy in severe COVID-19 patients with acute respiratory distress syndrome

(2020) Abolghasem Allahyari et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

(2020) David M. Weinreich et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia

(2020) Ventura A. Simonovich et al.   NEW ENGLAND JOURNAL OF MEDICINE

COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study

(2020) Sondas Alsharidah et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

A comparison of 12 algorithms for matching on the propensity score

(2013) Peter C. Austin   STATISTICS IN MEDICINE

A critical appraisal of propensity-score matching in the medical literature between 1996 and 2003

(2007) Peter C. Austin   STATISTICS IN MEDICINE